Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Sometimes the most telling question isn't 'where is this relationship going?' But 'if this relationship were an item of ...